109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
RNA targeting in alpha-synucleinopathies
#11102Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
#11103Aptamer that recognizes peptide
#11104Cofilin knockdown host cells and uses thereof
#11105Methods for modulating embryonic stem cell differentiation
#11106Lipophilic polynucleotide conjugates
#11107Lipid compositions
#11108Pancreatic cancer targets and uses thereof
#11109POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#11110RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#11111Targeting MicroRNAs for metabolic disorders
#11112Transcriptional repression leading to Parkinson's disease
#11113REGULATION OF AGING BY MODULATION OF MITOCHONDRIAL FUNCTION
#11114Use of LNA ApoB antisense oligomers for the treatment of acute coronary syndromes
#11115Methods for enhancing utrophin production via inhibition of microRNA
#11116Mannose-6-phosphate receptor mediated gene transfer into muscle cells
#11117Cell Cycle Arrest and Apoptosis
#11118ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
#11119METHODS FOR DETECTING A POLYMORPHISM IN THE NFKB1 GENE PROMOTER
#11120METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
#11121Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#11122RNA sequence-specific mediators of RNA interference
#11123SMALL INTERFERING RNA DELIVERY
#11124THERAPEUTIC AGENT AND ASSAY
#11125DROUGHT TOLERANT PLANTS AND RELATED CONSTRUCTS AND METHODS INVOLVING GENES ENCODING MIR827
#11126Treatment of neurological disorders
#11127Potent anti APOB antisense compounds
#11128ANTI-CANCER AGENT, METHOD FOR INDUCING APOPTOSIS OF CANCER CELLS, AND METHOD FOR SCREENING FOR ANTI-CANCER AGENT
#11129Modulation of STAT 6 expression
#11130COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN
#11131MIRNA AND ITS TARGETS RESPECTIVELY THE PROTEINS MADE BASED ON THE TARGETS AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR CANCER
#11132ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#11133Micro-RNA mediated modulation of colony stimulating factors
#11134Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment
#11135Oligomeric compounds and compositions for the use in modulation of target nucleic acids
#11136Anti-MicroRNA oligonucleotide molecules
#11137COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
#11138CARBON NANOTUBES COMPLEXED WITH MULTIPLE BIOACTIVE AGENTS AND METHODS RELATED THERETO
#11139siRNA conjugate and preparation method thereof
#11140Modifications for Antisense Compounds
#11141Use of microrna-199b-5p in medical and diagnostic field
#11142COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR OXIDATIVE STRESS AND RETINITIS PIGMENTOSA
#11143Oligomers
#11144Oligomers
#11145THERAPEUTIC USES OF INHIBITORS OF RTP801L
#11146Compositions for conferring tolerance to viral disease in social insects, and the use thereof
#11147MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMA
#11148DOUBLE-STRANDED OLIGONUCLEOTIDES
#11149GEMM RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH GEMM RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH GEMM RIBOSWITCHES
#11150METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULES
#11151Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3
#11152Compositions and methods for inhibiting expression of huntingtin gene
#11153NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#11154Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
#11155MicroRNAs and uses thereof
#11156Increasing protein production by increasing ABC50 expression or activity
#11157METHOD FOR SCREENING FOR DIET PROVIDING PRODUCTION OF MILK HAVING IMMUNOREGULATORY ACTION
#11158Methods of modulating smooth muscle cell proliferation and differentiation
#11159Compositions for bacterial mediated gene silencing and methods of using same
#11160Anti-connexin compounds targeted to connexins and methods of use thereof
#11161METHODS FOR OPTIMIZING ELECTROPORATION
#11162Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
#11163Head-and-neck tumor proliferation inhibitor
#11164Modified oligonucleotide and its preparation and application
#11165METHOD FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#11166IKKALPHA AND IKKBETA SPECIFIC INHIBITORS
#11167INHIBITION OF TRIM62 ACTIVITY REDUCES CANCER CELL PROLIFERATION
#11168Pharmaceutical Composition
#11169MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI
#11170Modified Cell Lines for Increasing Lentiviral Titers
#11171Antisense modulation of C-reactive protein expression
#11172Antisense modulation of PTP1B expression
#11173Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
#11174Methods for affecting homology-directed DNA double stranded break repair
#11175JNK INHIBITORS FOR USE IN TREATING SPINAL MUSCULAR ATROPHY
#11176Use of a growth-stimulating protein
#11177Method of diagnosing poor survival prognosis colon cancer using miR-29a
#11178Method of diagnosing poor survival prognosis colon cancer using miR-103-2
#11179Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
#11180MicroRNA and methods for inhibiting same
#11181Tetrahydropyran nucleic acid analogs
#11182Nucleic acid chemical modifications
#11183TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE
#11184Micro-RNA associated with rheumatoid arthritis
#11185Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer
#11186METHODS AND COMPOSITIONS RELATED TO PREFOLDIN AND ITS REGULATION
#11187Test agent for visceral obesity and use thereof
#11188Identification of a JAK2 mutation involved in vaquez polyglobulia
#11189MIR-21 promoter driven targeted cancer therapy
#11190SiRNA targeting apolipoprotein B (APOB)
#11191Methods and compositions involving miRNA and miRNA inhibitor molecules
#11192Oligomers
#11193Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#11194Lipids, lipid complexes and use thereof
#11195Methods and compositions for the treatment of cancer or other diseases
#11196METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21
#11197Method of diagnosing poor survival prognosis colon cancer using miR-106a
#11198TREATMENT OF AUTOIMMUNE INFLAMMATION USING MIR-155
#11199Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#11200DIFFERENTIATION THERAPY FOR SARCOMAS
#11201METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
#11202Therapeutic and diagnostic strategies
#11203Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
#11204Compound and method for treating myotonic dystrophy
#11205Method of diagnosing poor survival prognosis colon cancer using miR-10a
#11206Method of diagnosing poor survival prognosis colon cancer using miR-203
#11207Method of diagnosing poor survival prognosis colon cancer using miR-16b
#11208Method of diagnosing poor survival prognosis colon cancer using let-7g
#11209Method of diagnosing poor survival prognosis colon cancer using miR-181b
#11210Method for diagnosing acute lymphomic leukemia (ALL) using miR-125b
#11211RNAi expression constructs
#11212METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES
#11213METHOD OF TREATMENT OF VASCULAR COMPLICATIONS
#11214Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics
#11215Prevention and treatment of disease in bees
#11216Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders
#11217Splice-region antisense composition and method
#11218miR-33 INHIBITORS AND USES THEREOF
#11219COMPOSITIONS AND METHODS FOR MICRO-RNA EXPRESSION PROFILING OF CANCER STEM CELLS
#11220METHODS AND COMPOSITIONS RELATED TO THE REGULATION OF GOBLET CELL DIFFERENTIATION, MUCUS PRODUCTION AND MUCUS SECRETION
#11221METHODS AND COMPOSITIONS FOR SELECTING SIRNA OF IMPROVED FUNCTIONALITY
#11222Expression of apoAI and variants thereof using spliceosome mediated RNA -splicing
#11223Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
#11224Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
#11225Multi-targeting short interfering RNAs
#11226OLIGONUCLEOTIDE COMPRISING AN INOSINE FOR TREATING DMD
#11227Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles
#11228TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP
#11229Method for diagnosing acute lymphomic leukemia (ALL) using miR-146a
#11230Method for diagnosing acute lymphomic leukemia (ALL) using miR-222
#11231Method for diagnosing acute lymphomic leukemia (ALL) using miR-221
#11232CELL ADHESION INHIBITOR AND APPLICATIONS THEREOF
#11233JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS
#11234MicroRNAs In Idiopathic Pulmonary Fibrosis
#11235COMPOSITE POLYNUCLEIC ACID THERAPEUTICS
#11236Delivery of dsRNA to arthropods
#11237Compositions and Methods to Treat Muscular & Cardiovascular Disorders
#11238Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
#11239Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11240COMPOSITIONS AND METHODS RELATING TO miR-31
#11241Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions
#11242miRNA TARGETS
#11243Reduced size self-delivering RNAi compounds
#11244TREATMENT OF RADIATION-INDUCED FIBROSIS
#11245Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
#11246Whole seed specific promoter
#11247Method for inhibiting the activity of mir-155
#11248RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#11249Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
#11250Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
#11251USE OF INHIBITORS OF PLAC8 ACTIVITY FOR THE MODULATION OF ADIPOGENESIS
#11252Antisense antiviral compounds and methods for treating a filovirus infection
#11253Chemical modifications of monomers and oligonucleotides with cycloaddition
#11254Aptamer regulated nucleic acids and uses thereof
#11255Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker
#11256Methods and compositions for root knot nematode control
#11257RNA sequence-specific mediators of RNA interference
#11258Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11259Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11260Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof
#11261Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11262Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome
#11263MODULATORS OF APOPTOSIS AND THE USES THEREOF
#11264RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
#11265Short interfering ribonucleic acid (siRNA) for oral administration
#11266Short interfering ribonucleic acid (siRNA) for oral administration
#11267Inhibiting serum response factor (SRF) to improve glycemic control
#11268METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE
#11269INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY
#11270Biodegradable lipids for the delivery of active agents
#11271Lipids and compositions for the delivery of therapeutics
#11272Methods and means for treatment of osteoarthritis
#11273MicroRNAs in Never-Smokers and Related Materials and Methods
#11274Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11275Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#11276RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#11277Short interfering ribonucleic acid (siRNA) for oral administration
#11278Means for inhibiting the expression of ANG2
#11279METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS
#11280Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
#11281ANTISENSE MODULATION OF CHOLESTERYL ESTER TRANSFER PROTEIN EXPRESSION
#11282BREAST CANCER RELATED GENE RQCD1
#11283Method of regulating NFATc2 activity in lymphocytes
#11284PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis
#11285Sustained release siRNA for ocular drug delivery
#11286Cancer antigen eEF2
#11287Structurally designed shRNAs
#11288Chimeric RGMa polypeptides
#11289ISOLATED NOVEL NUCLEIC ACID AND PROTEIN MOLECULES FROM CORN AND METHODS OF USING THOSE MOLECULES TO GENERATE TRANSGENE PLANTS WITH ENHANCED AGRONOMIC TRAITS
#11290RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#11291SMALL INTERFERENCE RNA COMPLEX WITH INCREASED INTRACELLULAR TRANSMISSION CAPACITY
#11292siRNA targeting Superoxide
#11293Enigma-Mdm2 interaction and uses thereof
#11294Methods for multiplexing recombinase polymerase amplification
#11295RNA sequence-specific mediators of RNA interference
#11296Antisense compositions and methods of making and using same
#11297Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements
#11298Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation
#11299Method for the diagnosis and prognosis of malignant diseases
#11300Single-stranded nucleic acid molecule for controlling gene expression
#11301TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER
#11302Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
#11303SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)
#11304METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#11305VEGETABILE MATERIAL, PLANTS AND A METHOD OF PRODUCING A PLANT HAVING ALTERED LIGNIN PROPERTIES
#11306ANNEXIN A11 AND ASSOCIATED GENES AS BIOMARKERS FOR CANCER
#11307COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION
#11308Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#11309Single walled carbon nanotube/sirna complexes and methods related thereto
#11310Compositions and Methods to Treat Bone Related Disorders
#11311Methods used in identifying glioblastoma
#11312TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#11313siRNA targeting cyclin-dependent kinase 4 (CDK4)
#11314SNPs of apolipoprotein B and modulation of their expression
#11315siRNA targeting gremlin
#11316SiRNA targeting histamine receptor H1
#11317Method for enhancing a function of a T cell
#11318Human telomerase catalytic subunit
#11319Targeting PAX2 for the treatment of breast cancer
#11320Method to trigger RNA interference
#11321SUPPRESSOR OF AP-1
#11322METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#11323UNA oligomer structures for therapeutic agents
#11324Modulation of exon recognition in pre-mRNA by interfering RNA structure
#11325RNAI BASED SELECTION SYSTEM
#11326Lipids and compositions for the delivery of therapeutics
#11327Lipids and compositions for the delivery of therapeutics
#11328Antibodies that bind polypeptides involved in the process of bone remodeling
#11329Compositions and their uses directed to huntingtin
#11330RNA interference mediating small RNA molecules
#11331BRANCHED CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM
#11332Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#11333PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS
#11334Compositions and methods for treating hepatic neoplasia
#11335METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#11336Compositions and methods for insecticidal control of stinkbugs
#11337MODIFIED snRNAs FOR USE IN THERAPY
#11338SELF REPLICATING RNA MOLECULES AND USES THEREOF
#11339NUCLEIC ACID DRUG FOR TREATMENT OF ALLERGIC DISEASE
#11340Methods and compositions for diagnosis and treatment of cancer
#11341COMPOSITIONS AND METHODS FOR COMBINED THERAPY OF DISEASE
#11342Method for controlling herbicide-resistant plants
#11343COLON CANCER TARGETS AND USES THEREOF
#11344LIPIDS, LIPID COMPLEXES AND USE THEREOF
#11345Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
#11346MODULATION OF TRANSTHYRETIN EXPRESSION
#11347Sensizitation of cancer cells to therapy using sina targeting genes from the 1P and 19Q chromosomal regions
#11348Pharmaceutical composition for treating dementia comprising ShRNA inhibiting S100a9 expression
#11349Means and methods for counteracting muscle disorders
#11350USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#113512′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use
#11352CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME
#11353Methods and compositions for localized agent delivery
#11354MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION
#11355ANTAGONISTS OF MIR-155 FOR THE TREATMENT OF INFLAMMATORY LIVER DISEASE
#11356INHIBITION OF VEGF-A SECRETION, ANGIOGENESIS AND/OR NEOANGIOGENESIS BY SINA MEDIATED KNOCKDOWN OF VEGF-C AND RHOA
#11357Genes of an otitis media isolate of nontypeable
#11358COMPOSITIONS AND METHODS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS
#11359RNA sequence-specific mediators of RNA interference
#11360METHOD OF INHIBITING GENE EXPRESSION
#11361Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#11362RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#11363Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
#11364Identification of a novel BHD gene
#11365MicroRNA fingerprints during human megakaryocytopoiesis
#11366Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1
#11367MODULATION OF OLFML-3 MEDIATED ANGIOGENESIS
#11368Agents and methods to elicit anti-tumor immune response
#11369Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
#11370CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)
#11371Multiblock copolymers
#11372Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof
#11373RNA sequence-specific mediators of RNA interference
#11374SiRNA targeting beta secretase (BACE)
#11375Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus
#11376siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same
#11377METHOD FOR MIR-125A IN PROMOTING HEMATOPOIETIC STEM CELL SELF RENEWAL AND EXPANSION
#11378METHOD OF INHIBITING PROLIFERATION OF HEPATIC STELLATE CELLS
#11379MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
#11380COLON DISEASE TARGETS AND USES THEREOF
#11381siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
#11382Compositions and methods for inhibiting expression of the HAMP gene
#11383Spinal muscular atrophy treatment via targeting SMN2 catalytic core
#11384Gene Silencing by Single-Stranded Polynucleotides
#11385COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#11386NURR-1 Interacting Protein (NuIP)
#11387ANTIBODIES AND PROCESSES FOR PREPARING THE SAME
#11388ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#11389Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
#11390METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53
#11391Reduced size self-delivering RNAi compounds
#11392Methods of modulating mesenchymal stem cell differentiation
#11393Delivery of agents using interfering nanoparticles
#11394STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#11395SYNGR4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS
#11396TREATMENT OF PROLIFERATIVE DISORDERS WITH A DEATH RECEPTOR AGONIST
#11397Molecular marker for cancer stem cell
#11398MODULATING IMMUNE SYSTEM DEVELOPMENT AND FUNCTION THROUGH MICRORNA MIR-146
#11399Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#11400RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis